首页> Frontiers in oncology> Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ruiliang,Wang

第一单位： Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

作者： Ruiliang,Wang ^[1] ; Zongtai,Zheng ^[1] ; Shiyu,Mao ^[1] ; Wentao,Zhang ^[1] ; Ji,Liu ^[1] ; Cheng,Li ^[1] ; Shenghua,Liu ^[1] ; Xudong,Yao ^[1]

作者单位： Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. ^[1]

关键词 LASSO WGCNA bladder cancer malignant progression nomogram prognosis risk signature

DOI 10.3389/fonc.2021.632459

PMID 34268106

发布时间 2021-07-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2021年11卷

632459页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Frontiers in oncology

2021年11卷

632459页

检索历史清除

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.

Frontiers in oncology

相似文献

同项目论文

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.

Frontiers in oncology

相似文献

同项目论文

Frontiers in oncology

相关期刊

检索历史清除